Top 10 Pharma & Life Science Education Institutions - 2022

Education in India has undergone phenomenal growth post independence, especially, during the past few years, as Indians realised that education is the ideal route for social and economic growth of individual and society. Professionals from India are of great demand all over the world. Today's technology driven knowledge based economy requires qualified and skilled man power with expertise in their field. Several disciplines, including science, engineering, technology and management fields, have shown tremendous growth potential in Indian education system. New streams are gaining importance in education now a days, contribution of life science s to the growth of society is remarkable, and has influenced every walk of human life.

Life science covers basic life sciences like botany, zoology, along with medical, biomedical, paramedical, pharmaceutical and other life and health-related areas. These areas have seen exponential growth in past two decades.  Various life sciences industry branches may include pharmaceuticals, biotechnology, environmental sciences, biomedicine, nutraceuticals, neuroscience, cell biology, biophysics, and many others. It is important in understanding the nature of diseases, and hence it has a lot of importance at present stage and in the future, where diseases both caused by genetic disorders and pathogen attacks are increasing day by day. 

Curriculum is the core of any programme which acts as the differentiator amongst many equals.  Curriculum has to be always in line with the rapidly emerging trends, especially in the life sciences area, like developments in medicines, emerging of diseases unknown earlier, development of newer diagnostic devices and medical procedures.

Higher Education Review, in this issue presents a list of `Top 10 Pharma & Life Science Education Institutions ­ 2022', who have already succeeded in carving out some of the most successful leaders in this field. The following list has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts and our editorial board.